Designing and generating RWE for regulatory submissions including externally controlled trials (ECTs), natural history, benchmarking studies, and epidemiological support on orphan drug applications, pediatric study plans, diversity plans, and (s)BLAs/(s)NDAs.

Designing and conducting a range of observational studies including burden of disease, comparative effectiveness & safety, and external control arms. We provide end-to-end execution including study design, protocol and analysis plan writing, analysis, study report, and publications.

Conducting targeted or systematic literature reviews to inform comparative effectiveness and confounder selection, incidence and prevalence across indications, treatment patterns, and outcomes.

Identifying suitable data sources for novel research questions and conducting data assessments & feasibility by indication to determine fitness of data. We have extensive experience with medical claims databases, electronic health record data, genomic, and registry data.

Designing and conducting healthcare resource utilization, budget impact models, and cost effectiveness studies and data to support HTA/payor needs.

Writing services include protocol and statistical analysis plan writing, and abstract, poster and manuscript development. Experience with medical writing in the context of real-world evidence.

Landmark Science, Inc.

P.O. Box #641819

Los Angeles, CA 90064

Landmark Science, Inc. is a premier life science research organization that provides a comprehensive suite of services enabling the use of RWE and HEOR in drug development. Landmark Science's team of experts deliver RWE and HEOR for clinical program strategy, health economics, commercial, market access, and regulators and payors to meet diverse needs efficiently.

Landmark Science ApS

Skolevej 3

8240 Aarhus, Denmark

Landmark Science ApS is a wholly owned Danish subsidiary of Landmark Science, established to serve clients across the EU with localized operations, data partnerships, and compliance capabilities. The company provides EU‑ready RWE and HEOR services, from study design and data acquisition to analysis, modeling, and evidence communication.